Brevia Health deepens vaccines expertise with Nick Lowen appointment

Brevia Health has deepened our vaccines expertise with the appointment of Nick Lowen as an Associate with over 30 years’ life sciences experience including serving as Vice President, Commercial Strategic Projects at GSK.  During his time at GSK, Nick successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, he oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.  Nick joins our senior team of advisers that include Gillian Leng CBE (former CEO, NICE), Jonathan Mogford (former Director of Policy, MHRA) and Mike Thompson MBE (former CEO, ABPI).

Nick trained as a pharmacist and began his career in the NHS.  Before joining the Biopharma industry, he was one of the UK’s first regional NHS Pharmaceutical advisers.

He joined GSK in 1997 where he worked for over 25 years and held a number of senior leadership roles.  During this period, he successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, Nick oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.

In addition to Vaccines, Nick has therapeutic experience in Neurology, Dermatology, Anti-infectives, Respiratory, Oncology and specialist medicines.

Nick has a passion for delivering marketing and sales excellence across Global, EU and UK Pharmaceutical markets through launching innovative products, life cycle management and building market access.  He has a strong track record managing teams to create and deliver strategic business change in Pharma, including managing the transition to outsource operations in multiple countries, creating business development opportunities, and negotiating and concluding significant business deals.

 

BREVIA HEALTH PROVIDES STRAIGHTFOWARD PUBLIC AFFAIRS AND PUBLIC RELATIONS SUPPORT TO BUSINESSES AND CHARITIES OPERATING IN THE HIGHLY REGULATED UK HEALTHCARE SECTOR

Discover how Brevia can help you and your organisation by viewing our Health services or contacting the Brevia Team on 020 7091 1650 or emailing us at contact@brevia.co.uk

 

 

 

 

 

LATEST NEWS

Energy

What the UK Infrastructure Strategy Means for the Energy Sector

The UK Government has unveiled its Infrastructure Strategy, placing energy at the centre of national ambitions for growth, decarbonisation, and resilience. With major reforms across planning, regulation, and investment, the Infrastructure Strategy sets a new agenda for how infrastructure will be developed, funded, and delivered over the next decade. This marks not just a shift in policy but a strategic inflection point for the future of the energy sector. In this article, Brevia Energy unpacks the implications and opportunities for the sector.

Read More »
Politics

The Strategic Defence Review

On 2 June 2025, the Government published the Strategic Defence Review, the first such review since 2021. The Review sets out principles for UK Defence, in order to respond to new threats that have arisen in the last four years.

Read More »
Energy

Spending Review: What to look out for on energy

Next week’s Spending Review will set departmental budgets for the next three years, shaping the long-term direction of energy policy, infrastructure investment, and the Government’s net zero agenda. In this article, Brevia Energy explores what to watch for in the energy brief.

Read More »